Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Pathological neovascularization is a hallmark of late stage neovascular (wet) age-related macular degeneration (AMD) and the leading cause of blindness in people over the age of 50 in the western world. The treatments focus on suppression of choroidal neovascularization (CNV), while current approved...

Full description

Bibliographic Details
Main Authors: Ofra Benny, Kei Nakai, Takeru Yoshimura, Lauren Bazinet, James D Akula, Shintaro Nakao, Ali Hafezi-Moghadam, Dipak Panigrahy, Pouya Pakneshan, Robert J D'Amato
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-09-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2931703?pdf=render

Internet

http://europepmc.org/articles/PMC2931703?pdf=render

Similar Items